# Neuronostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuronostics

- Industry: Medical Devices & Equipment
- Headquarters: Bristol, UK
- Website: www.neuronostics.com
- Total disclosed funding: $0.7M
- Latest round: Seed (Mar 30, 2021)
- Investors on record: 1

## About

Founded in 2018 by John Terry (MD), and based in Bristol, UK, Neuronostics Ltd, a spin-out of the University of Exeter, operates as a manufacturer of medical devices that allows users to identify, manage, and treat neurological disorders. In March 2021, Neuronostics Ltd raised GBP 300,000 in seed funding from new investor QantX. Some of the firm’s partners include NHS, the University of Birmingham, the University of Exeter, Kings’s College London, Epilepsy Action, etc. 

The company creates patented technology that uses mathematical modeling and advanced AI (artificial intelligence) tools to provide objective decision support to healthcare professionals in order to help inform the risk of epileptic seizures, allowing for faster and more accurate epilepsy diagnosis and prognosis.

## Funding rounds

- Seed, Mar 30, 2021, $0.7M — QantX

## Investors

- QantX (https://capitalatlas.ai/funds/qantx) — Seed